Use Of statins in the Elderly

Bibliography

• 18th Bethesda conference report: Cardiovascular disease in the elderly. May 8–10 1986. J. Am. Coll. Cardiol. 10, 1A (1987).
   Google Scholar
• Kreisberg RA, Kasim S: Cholesterol metabolism and aging. Am. J. Med. 82, 54–60 (1987).
   Google Scholar
• Ericsson S, Eriksson M, Vitols S et al.: Influence of age on the metabolism of plasma low density lipoproteins in healthy males. J. Clin. Invest. 87, 591–596 (1991).
   Google Scholar
• Corti MC, Guralnik JM, Salive ME et al.: HDL cholesterol predicts coronary heart disease mortality in older persons. JAMA 274, 539–544 (1995).
   Google Scholar
• Castelli WP, Wilson PW, Levy D et al.: Cardiovascular risk factors in the elderly. Am. J. Cardiol. 63, H12–H19 (1989).
   Google Scholar
• Frost PH, Davis BR, Burlando AJ et al.: For the Systolic Hypertension in the Elderly Research Group. Serum lipids and incidence of coronary heart disease. Findings from the Systolic Hypertension in the Elderly Program (SHEP). Circulation 94, 2381–2388 (1996).
   Google Scholar
• Miettinen TA, Pyorala K, Olsson AG et al.: for the Scandinavian Simvastatin Study Group. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 96, 4211–4218 (1997).
   Google Scholar
• Lewis SJ, Moye LA, Sacks FM et al.: For the CARE Investigators. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Ann. Intern. Med. 129, 681–689 (1998).
   Google Scholar
• Hunt D, Young P, Simes J et al.: Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: results from the LIPID trial. Ann. Intern. Med. 134, 931–940 (2001).
   Google Scholar
• Sever PS, Dahlof B, Poulter NR et al.: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo- Scandinavian Cardiac Outcomes Trial – Lipid Lowering Arm (ASCOT-LLA): a multicentre study of patients randomized in the Scandinavian Simvastatin randomised controlled trial. Lancet 361, 1149–1158 (2003).
   Google Scholar
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebocontrolled trial. Lancet 360, 7–22 (2002).
   Google Scholar
• Shepherd J, Blauw GJ, Murphy MB et al.: Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 360, 1623–1630 (2002).
   Google Scholar
• Lemaitre RN, Psaty BM, Heckbert SR et al.: Therapy with hydroxymethylglutaryl coenzyme a reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: evidence from the cardiovascular health study. Arch. Intern. Med. 162, 1395–1400 (2002).
   Google Scholar
• Mehta JL, Bursac Z, Hauer-Jensen M, Fort C, Fink LM: Comparison of mortality rates in statin users versus nonstatin users in a United States veteran population. Am. J. Cardiol. 98(7), 923–928 (2006).
   Google Scholar
• Schwartz GG, Olsson AG, Ezekowitz MD et al.: Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study: a randomized controlled trial. JAMA 285, 1711–1718 (2001).
   Google Scholar
• Fedson DS: Pandemic influenza: a potential role for statins in treatment and prophylaxis. Clin. Infect. Dis. 43(2), 199–205 (2006).
   Google Scholar
• Klein BE, Klein R, Lee KE, Grady LM: Statin use and incident nuclear cataract. JAMA 295(23), 2752–2758 (2006).
   Google Scholar
• Cauley JA, McTiernan A, Rodabough RJ et al.: Women's Health Initiative Research Group. Statin use and breast cancer: prospective results from the Women’s Health Initiative. J. Natl Cancer Inst. 98(10), 700–707 (2006).
   Google Scholar
• Mendelson G, Aronow WS: Underutilization of measurement of serum low-density lipoprotein cholesterol levels and of lipid lowering therapy in older patients with manifest atherosclerotic disease. J. Am. Geriatr. Soc. 46, 1128–1131 (1998).
   Google Scholar
• Cannon CP, Braunwald E, McCabe CH et al.: Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N. Engl. J. Med. 350, 1495–1504 (2004).
   Google Scholar
• Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285, 2486–2497 (2001).
   Google Scholar
• Grundy SM, Cleeman JI, Merz CNB et al.: Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110, 227–239 (2004).
   Google Scholar